We are currently looking to understand the pharma distribution strategy adopted by orphan drug (drugs to treat rare disease) manufacturers in australia. We know that australian market is dominated by three major cso distributors (api, sigma and x
b) and major generic drug manufacturers prefer to engage with these 3 wholesalers as they have the maximum distribution point of sales and are required to supply drugs listed in pbs.
1. So based on this, would like to know if orphan drug manufacturers also use these wholesalers or do they prefer direct distribution using dhl or world couriers, or any other strategy?
2. Would like to get some case specific to orphan drug distribution in australia.
Thank you and looking forward.
+undefined Other Responses
Orphan Drug Reimbursement
Looking to interview 3 experts from the managed care industry, employed by health plans, and having experience on reimbursement issues for orpahn drugs for rare diseases+16 Other Responses
Creative Services For Pharmaceuticals
Creative and digital agency for pharmaceuticals
- what is the best sourcing model for creative and digital services for pharmaceutical companies?
- what is the sourcing approach followed typically by leading pharmaceutical companies? (full-service model or specialized agency model)?
- do large pharma/vaccines companies bundle digital and creative work to single agencies?
- what is the most optimal pricing model while engaging with digital and creative agencies to assure transparency and control of costs?
- is fixed price or performance based pricing or any other?
- i would like to understand if fixed price model is most effective pricing model to control costs while engaging with creative and digital agencies.+10 Other Responses
Looking for experts for pharmaceutical manufacturing as small unit. How can i start.+28 Other Responses
Topic: orphan drug space
we are a global research firm and an authorized zintro partner looking for experts who could consult for a study on the orphan drug space in europe and americas.
Ideal candidates would be medical doctors, pharmaceutical professionals, and/or regulatory experts.
If interested, please briefly describe your experience in this space, and the disease areas you are most familiar with.
The expert needs to be available to consult with us via phone consultations. If interested, please contact me. Thanks!+13 Other Responses
Pharmaceuticals, Vaccines And Consumer Products Distribution
"pharmaceuticals, vaccines and consumer products-distribution sourcing"
1. Sourcing best practice
a. What are the sourcing approaches followed by global organizations when dealing with distributors/wholesalers across pharmaceutical, consumer and vaccine business? (centralized/decentralized)
2. Engagement best practice
a. What is the best practice followed by companies when engaging for distribution services across pharmaceutical, consumer and vaccine business?
I. Is it engaging with a distributor or wholesaler?
· global/regional/local distributors?
· single or multiple distributors?
3. Feasibility of integrating the distribution model for pharmaceuticals, consumer and vaccine business
a. How do companies with multiple business units such as pharmaceutical, consumer and vaccine business manage this category?
I. Is there a chance of integrating the distribution of these three business units with single set of distributors?
Ii. What are the advantages and disadvantages of following the integration approach?+9 Other Responses
Us Pharmaceutical Manufacturing
Our us firm requires us experts in pharmaceutical manufacturing,
ideally someone familiar with testing procedures, production lines and the equipment used to monitor production of common pharmaceuticals (pills / tablets.)
- we prefer someone with a technical or manufacturing / operations (e.G., quality control) background.
Referrals are also welcomed, thank you.+undefined Other Responses
Pharmaceutical Taste Masking
Established pharmaceutical company wants to outsource formulation and gmp manufacture of rapid dissolving and bitter taste masking tablet for sublingual use. Need experts in taste masking formulations.+7 Other Responses
Rare Disease Generics
I am looking to speak with knowledgeable contacts in the pharmaceutical industry with experience in the area of rare disease generics. I am interested to learn about companies such as par pharmaceuticals, hetero, and apotex who are developing generics in the rare disease space. The knowledge source should have an understanding of the mentioned generic company’s capabilities.+undefined Other Responses
Pharmaceutical Contract Sales
Project : study on pharmaceutical companies sourcing sales reps from contract sales organizations
industry: pharmaceuticals, contract sales
scope: australia, belgium, netherlands, saudi arabia, puerto rico, venezuela.
We are doing a project on procuring sales force from contract sales organizations in various markets. Request expert guidance in understanding the procurement best practices followed by leading pharmaceutical companies while sourcing contract sales reps from contract sales organizations+9 Other Responses
Hi zintro expert,
the zintro blog needs you!
*a brief answer to the prompt about 1-2 paragraphs including your full name
*participation is voluntary no payment will be involved
*if chosen, you will be named in the post and we'll include a link to your zintro profile which will generate more visitors for you
topic and prompt
global pharmaceuticals companies have seen an improvement in their drugs pipelines but the industry is facing a fresh challenge as the first generation of blockbuster biological drugs begins to face competition. Bristol-myers squibb and eli lilly have the strongest late-stage pipelines relative to existing revenues, while astrazeneca has shown the greatest improvement over the past two years, says a report by credit rating agency moody’s. However, those same three companies also face the greatest exposure to patent expiries over the next three years, highlighting the perennial battle faced by drugmakers to develop new medicines as old ones lose market exclusivity.
What are your thoughts?
Getting your name and expert opinion published on our blog is a great marketing opportunity. If interested, please send a response to the prompt via znotes within 1-2 days. Don't forget to include your full name.
If you have any questions, please let us know.
the zintro blog team
wondering what the post would look like? Here is a sample:
/>+4 Other Responses
Hi zintro expert,the zintro blog needs you! we are looking for expert opinions on the news mentioned below and would like to include your point of view.
we realize your time is valuable, so here is a brief summary of what we are looking for:
*a brief answer to the prompt about 1-2 paragraphs including your full name*participation is voluntary no payment will be involved*if chosen, you will be named in the post and we'll include a link to your zintro profile which will generate more visitors for you
topic and prompt
teva pharmaceutical industries ltd. And active biotech ab said monday they were ending the higher-dose portions of two multiple-sclerosis studies with the drug laquinimod after eight patients suffered nonfatal cardiovascular events.The companies said the incidents occurred in the higher-dose components of a phase 3 and a phase 2 clinical trial. The lower-dose and placebo components of the tests will continue.Phase 3 clinical trials are typically the last phase before a drug gets approval from the u.S. Food and drug administration.Teva shares fell 1.3% in early trading in new york, and active biotech shares fell by about one-third in stockholm.Laquinimod is a once-daily oral drug being developed for treating multiple sclerosis and huntington disease.
What are your thoughts?
Getting your name and expert opinion published on our blog is a great marketing opportunity. if interested, please send a response to the prompt via znotes within 1-2 days.Don't forget to include your full name.If you have any questions, please let us know.Thank you!
the zintro blog team
wondering what the post would look like? Here is a sample: http://blog.Zintro.Com/2014/08/14/rosetta-completes-10-year-trip-deep-space/>+7 Other Responses